Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 0 | 3,144 | 2,310 | 2,650 | 0 |
| Gross Profit | N/A | 3,144 | 2,310 | 2,650 | 27,840 |
| Operating Expenses | 20,498 | 13,231 | 16,580 | 22,940 | 33,690 |
| Operating Income | -20,498 | -10,087 | -14,270 | -20,290 | -33,690 |
| Other Income | 251 | 309 | 10 | -350 | 0 |
| Pre-tax Income | -20,247 | -9,778 | -14,260 | -20,640 | -33,690 |
| Income Tax | 39 | N/A | 4 | 110 | N/A |
| Net Income Continuous | -20,286 | -9,778 | -14,264 | -20,750 | -33,690 |
| Net Income | $-20,286 | $-9,778 | $-14,260 | $-20,750 | $-33,690 |
| EPS Basic Total Ops | -3.00 | -99.00 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -3.00 | -98.89 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.00 | -99.00 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -3.00 | -98.89 | N/A | N/A | N/A |
| EBITDA(a) | $-20,375 | $-9,890 | $-13,590 | $-19,430 | $-32,470 |